Publications | Lund University Publications

21 – 30 of 134

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=department+exact+V1001088&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
5
…
14
next »

2024
Mark Ovanligt symtom med hög klinisk valör vid Hodgkins lymfom
Lanke, Elsa and Relander, Thomas ^LU (2024) In Lakartidningen 121.
- Contribution to journal › Article
Mark Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
Harrysson, Sara ; Eloranta, Sandra ; Ekberg, Sara ; Enblad, Gunilla ; Andersson, Per Ola ; Sonnevi, Kristina ; Ljungqvist, Maria ; Sander, Birgitta ; Jerkeman, Mats ^LU and Smedby, Karin E. (2024) In Leukemia and Lymphoma 65(4). p.534-537
- Contribution to journal › Letter
Mark Infections in patients with mantle cell lymphoma
Abalo, Kossi D. ; Ekberg, Sara ; Andersson, Therese M.L. ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Smedby, Karin E. ; Jerkeman, Mats ^LU and Glimelius, Ingrid (2024) In HemaSphere 8(7).
- Contribution to journal › Article
Mark Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
Martelli, M. ; Jerkeman, M. ^LU and Zucca, Emanuele (2024) In Journal of Clinical Oncology 42(34). p.4071-4083
- Contribution to journal › Article
Mark MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 – a Nordic Lymphoma Group study
Rodrigues, Joana M. ; Hollander, Peter ; Schmidt, Lina ^LU ; Gkika, Eirinaios ^LU ; Razmara, Masoud ; Kumar, Darshan ; Geisler, Christian ; Grønbæk, Kirsten ; Eskelund, Christian W. and Räty, Riikka , et al. (2024) In Haematologica 109(4). p.1171-1183
- Contribution to journal › Article
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up^☆
Ferreri, A. J.M. ; Illerhaus, G. ; Doorduijn, J. K. ; Auer, D. P. ; Bromberg, J. E.C. ; Calimeri, T. ; Cwynarski, K. ; Fox, C. P. ; Hoang-Xuan, K. and Malaise, D. , et al. (2024) In Annals of Oncology 35(6). p.491-507
- Contribution to journal › Article
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ferreri, Andreas J.M. ; Illerhaus, Gerald ; Doorduijn, Jeanette K. ; Auer, Dorothee P. ; Bromberg, Jacoline E.C. ; Calimeri, Teresa ; Cwynarski, Kate ; Fox, Christopher P. ; Hoang-Xuan, Khê and Malaise, Denis , et al. (2024) In HemaSphere 8(6).
- Contribution to journal › Article
Mark Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE) : Protocol for a Translational Study
Belfrage, Emma ^LU ; Ek, Sara ^LU ; Johansson, Åsa ^LU ; Brauner, Hanna ; Sonesson, Andreas ^LU and Drott, Kristina ^LU (2024) In JMIR Research Protocols 13.
- Contribution to journal › Article
Mark Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE) : a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva ; Jerkeman, Mats ^LU ; Walewski, Jan ; Hutchings, Martin ; Mey, Ulrich ; Riise, Jon ; Trneny, Marek and Vergote, Vibeke , et al. (2024) In The Lancet 403(10441). p.2293-2306
- Contribution to journal › Article
Mark Tattoos as a risk factor for malignant lymphoma: a population-based case–control study
Nielsen, Christel ^LU ; Jerkeman, Mats ^LU and Jöud, Anna ^LU (2024) In EClinicalMedicine 72.
- Contribution to journal › Article

« previous
1
2
3
4
5
…
14
next »

your query:: Remove department: Lymphoma - Clinical Research